Peer Review reports
From: Pembrolizumab induced-C3 glomerulonephritis and RBC cast nephropathy: a case report
Original Submission | ||
---|---|---|
6 Dec 2022 | Submitted | Original manuscript |
23 Feb 2023 | Reviewed | Reviewer Report - Velimir Peric |
28 Mar 2023 | Reviewed | Reviewer Report - Zeynep Ural |
1 Apr 2023 | Reviewed | Reviewer Report |
7 Apr 2023 | Author responded | Author comments - Zhangxue Hu |
Resubmission - Version 2 | ||
7 Apr 2023 | Submitted | Manuscript version 2 |
9 Apr 2023 | Author responded | Author comments - Zhangxue Hu |
Resubmission - Version 3 | ||
9 Apr 2023 | Submitted | Manuscript version 3 |
20 Apr 2023 | Reviewed | Reviewer Report - Zeynep Ural |
4 May 2023 | Reviewed | Reviewer Report - Velimir Peric |
Resubmission - Version 4 | ||
Submitted | Manuscript version 4 | |
Publishing | ||
17 May 2023 | Editorially accepted | |
24 May 2023 | Article published | 10.1186/s12882-023-03202-5 |
You can find further information about peer review here.